Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Tetrous

## Sitemaps
[XML Sitemap](https://tetrous.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [Tetrous® Wins “Most Exciting New Product” Award at Shoulder 360™](https://tetrous.com/2026/05/tetrous-wins-most-exciting-new-product-award-at-shoulder-360/): LOS ANGELES, May 7, 2026 /PRNewswire/ -- Tetrous, Inc., an emerging leader in orthopedic sports medicine innovation, today announced it has been awarded "Most Exciting New Product" at Shoulder 360, recognizing the company's continued advancement in solutions for bone-to-tendon healing.
- [Tetrous® Announces Completion of First Cases with EnFix ACL™ for ACL Reconstruction](https://tetrous.com/2026/04/tetrous-announces-completion-of-first-cases-with-enfix-acl-for-acl-reconstruction/): LOS ANGELES, April 7, 2026 /PRNewswire/ -- Tetrous, Inc., an innovative orthopedic company focused on advancing biology in bone-to-tendon healing following orthopedic surgery, today announced the first Anterior Cruciate Ligament (ACL) Reconstruction cases completed in the U.S. and Australia using a new implant, the EnFix ACL, a 100% demineralized bone fiber (DBF) implant, as Tetrous expands into additional clinical applications in the knee.
- [Tetrous® Strengthens Commercial Leadership with Appointment of Thurman Ballard as Vice President of Sales](https://tetrous.com/2026/03/tetrous-strengthens-commercial-leadership-with-appointment-of-thurman-ballard-as-vice-president-of-sales/): Orthopedic industry veteran to lead U.S. commercial expansion and accelerate adoption of EnFix® demineralized bone fiber implants for bone-tendon healing in Sports Medicine and Foot and Ankle
- [TETROUS®, INC. GRANTED NEW U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR ENTHESIS REPAIR](https://tetrous.com/2026/01/tetrous-inc-granted-new-u-s-patent-related-to-enfix-demineralized-bone-fiber-implants-for-enthesis-repair/): Los Angeles, CA, January 13, 2026 – Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today that a sixth patent (U.S. Patent Number 12,502,459) related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office.
- [TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR](https://tetrous.com/2025/05/tetrous-inc-announces-expanded-clinical-applications-of-enfix-for-enthesis-repair/): Los Angeles, CA, May 20, 2025 – Tetrous, Inc., a Sherman Oaks-based company focused on biologic solutions for bone-to-tendon healing, announces expanded clinical use of its EnFix implants across multiple anatomical entheses beyond rotator cuff repair. New applications include proximal/distal biceps tenodesis, insertional Achilles tendinopathy, gluteus medius and proximal hamstring reattachment, lateral epicondyle repair, and subscapularis repair during total shoulder arthroplasty.
- [TETROUS®, INC. SIGNS NEW DISTRIBUTION AGREEMENT IN NEW ZEALAND TO EXPAND PRESENCE IN THE ASIA-PACIFIC MARKET AND ADDS DR. CRAIG BALL TO IT’S SURGEON ADVISORY BOARD](https://tetrous.com/2025/03/tetrous-inc-signs-new-distribution-agreement-in-new-zealand-to-expand-presence-in-the-asia-pacific-market-and-adds-dr-craig-ball-to-its-surgeon-advisory-board/): Los Angeles, CA, March 19, 2025 – Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, is pleased to announce the signing of a new distribution agreement with Alpha Medical, a well-established distributor in New Zealand. Additionally, Dr. Craig Ball, a pre-eminent shoulder surgeon in New Zealand has agreed to join Tetrous’ Clinical Advisory Board. These strategic partnerships will expand existing distribution of Tetrous products already fully commercialized in the US, and in Australia by Australian Biotechnologies, to now include distribution in New Zealand with Alpha Medical.
- [TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH](https://tetrous.com/2025/03/tetrous-inc-successfully-closes-financing-round-securing-additional-capital-for-future-growth/): Los Angeles, CA, March 10, 2025 – Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, is pleased to announce the successful closure of its Series A financing round, raising a total of $6,500,000. This round of financing was a Reg D offering available to accredited investors. It attracted a diverse group of investors, including a significant investment (over 50% of the raise) from strategic partners including our USA and Australian manufacturing and distribution partners, as well as investments from the management team, and existing shareholders. The round was expanded twice from the initial $5,000,000 target due to overwhelming interest and support from existing investors, strategic partners and new investors.
- [Advancements in Rotator Cuff Repair: The 2024 Shoulder and Elbow Society of Australia Meeting](https://tetrous.com/2025/02/advancements-in-rotator-cuff-repair-the-2024-shoulder-and-elbow-society-of-australia-meeting/): Kathleen Dailey1, Andy Carter, PhD1,2, William R. Walsh, PhD2, Ivan Popoff, MD3,6, Doron Sher, MD3,6, Kenneth Cutbush, MD4, Ashish Gupta, MD5, Jerome Goldberg, MD6
- [TETROUS®, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES](https://tetrous.com/2024/10/tetrous-inc-announces-issue-of-an-additional-u-s-patent-related-to-enfix-demineralized-bone-fiber-implants-for-sports-medicine-surgical-procedures-2/): Los Angeles, CA, October 15, 2024 – Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today that a fourth patent (U.S. Patent Number 12,115,279) specifically related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office.
- [TETROUS® wins ACE Award at the American Orthopaedic Society for Sports Medicine (AOSSM) conference for its EnFix® implant](https://tetrous.com/2024/08/tetrous-wins-ace-award-at-the-american-orthopaedic-society-for-sports-medicine-aossm-conference-for-its-enfix-implant/): Los Angeles, CA, AUGUST 1, 2024 – The TETROUS EnFix implant was awarded the coveted ACE Award for “Accelerating the Cutting Edge” during the annual meeting of the American Orthopaedic Society for Sports Medicine (AOSSM) in Denver in July.
- [TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC® DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR](https://tetrous.com/2024/05/tetrous-announces-first-surgical-procedures-using-enfix-tac-demineralized-bone-fiber-implants-to-enhance-enthesis-healing-in-rotator-cuff-repair/): Los Angeles, CA, MAY 8, 2024 – TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first surgical cases using EnFix TAC™, its latest product that expands its line of EnFix™ implants to cover every surgical technique for rotator cuff repair.
- [TETROUS, INC. ANNOUNCES THE LAUNCH OF THE ENFIX TAC® TO COMPLEMENT THE ENFIX RC® AS THE ONLY PRODUCT LINE OF 100% DEMINERALIZED BONE ALLOGRAFT IMPLANTS THAT ARE DESIGNED TO ENHANCE REFORMATION OF THE ENTHESIS IN ROTATOR CUFF SURGERY](https://tetrous.com/2024/02/tetrous-inc-announces-the-launch-of-the-enfix-tac-to-complement-the-enfix-rc-as-the-only-product-line-of-100-demineralized-bone-allograft-implants-that-are-designed-to-enhance-refo/): Los Angeles, CA, February 13, 2024 –TETROUS, INC. unveils the addition of EnFix TAC to its family of EnFix™ demineralized bone allograft implants for use in rotator cuff surgery.  The new implants will be showcased this week at the American Academy of Orthopaedic Surgeons (AAOS) annual conference in San Francisco, CA.
- [TETROUS, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES](https://tetrous.com/2023/10/tetrous-inc-announces-issue-of-an-additional-u-s-patent-related-to-enfix-demineralized-bone-fiber-implants-for-sports-medicine-surgical-procedures/): Los Angeles, CA, October 5, 2023 – Tetrous, Inc., a regenerative medicine company, today announced that another patent (U.S. Patent Number 11,759,548) specifically related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office.
- [TETROUS ANNOUNCES FIRST ENFIX RC® SURGICAL CASES OUTSIDE THE UNITED STATES](https://tetrous.com/2023/07/tetrous-announces-first-enfix-rc-surgical-cases-outside-the-united-states/): Tetrous Inc., a leading regenerative medicine company today announced that it has completed the first surgical cases in Australia using EnFix RC, a procedure-specific implant for rotator cuff repair that is specifically designed to address Enthesis Failure Syndrome. The procedures were performed successfully by Dr. Kenneth Cutbush, Dr. Ivan Popoff and Dr. Doron Sher.
- [FIRST SURGICAL PROCEDURES IN THE WORLD USING TETROUS ENFIX RC® FIBER IMPLANT TO ENHANCE ROTATOR CUFF REPAIR PERFORMED AT RUSH OAK BROOK SURGERY CENTER](https://tetrous.com/2023/07/first-surgical-procedures-in-the-world-using-tetrous-enfix-rc-fiber-implant-to-enhance-rotator-cuff-repair-performed-at-rush-oak-brook-surgery-center/): Tetrous Inc., a leading regenerative medicine company today announced that it has completed the first four surgical cases using EnFix RC, a procedure-specific implant for rotator cuff repair that is specifically designed to address Enthesis Failure Syndrome. Dr. Nikhil Verma, MD. Professor and Director, Division of Sports Medicine, Fellowship Director, Department of Orthopedics, Rush University Medical Center, Team Physician Chicago White Sox and Chicago Bulls, who performed the first four surgeries with the EnFix RC said: "I was thrilled to be the first surgeon to deploy the EnFix RC. I used one EnFix RC in each case to augment the medial suture anchor fixation. Initially I was impressed with the concept of flipping the script compared to most of the products today for surgical augmentation. I also was very pleased with how the implant and instrument design was optimized, simplifying the delivery of the product into the interface between the tendon and the bone. The procedure is minimally disruptive to the way rotator cuff surgeries are typically performed. I plan to use the EnFix RC routinely moving forward."
- [TETROUS, INC. ANNOUNCES ISSUE OF U.S. PATENT RELATED TO THE ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES](https://tetrous.com/2023/07/tetrous-inc-announces-issuance-of-u-s-patent-related-to-the-enfix-demineralized-bone-fiber-implants-for-sports-medicine-surgical-procedures/): Tetrous, Inc., a regenerative medicine company, today announced that a patent (U.S. Patent Number 11,660,373) related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office.

## Pages
- [Privacy Policy](https://tetrous.com/privacy-policy/): Last Updated: September 8, 2025
- [Resources](https://tetrous.com/resources/): Ashish Gupta, MDJune 2025
- [Contact Us – New](https://tetrous.com/contact-us-new/): Phone:  +1 331-307-7499Email:  customerservice@tetrous.com
- [News](https://tetrous.com/news/): News
- [Events](https://tetrous.com/events/): Dec 12-14, 2024
- [Instruments](https://tetrous.com/products/instruments/): TET-INS-016
- [Technology](https://tetrous.com/products/technology/): The EnFix products are allogenic tissue products that conform to the Food and Drug Administration’s (FDA) regulations governing human and cellular tissue-based products (HCT/P) according to 21 CFR Part 1271 and Section 361 of the PHS Act. The processes used to manufacture EnFix products were designed to cause minimal changes to the allograft tissue and to maintain the osteoinductive potential. The products are 100% cortical bone and contain no additives or excipients.
- [EnFix RC®](https://tetrous.com/products/enfix-rc/): https://youtu.be/VSlH70u6KLY
- [EnFix TAC®](https://tetrous.com/products/enfix-tac/): ”EnFix® is designed to minimally disrupt the way rotator cuff repairs are performed, simplifying the delivery of the product into the interface between the bone and the tendon flipping the script compared to most of the products today for augmentation.” Nikhil Verma, MD. Professor and Director, Division of Sports Medicine, Fellowship Director, Department of Orthopedics, Rush University Medical Center, Team Physician Chicago White Sox and Chicago Bulls, Board Director, Tetrous, Inc.
- [Tetrous, Inc. – It’s All About the Enthesis®](https://tetrous.com/): TAC-T
- [Products](https://tetrous.com/products/): ”EnFix is designed to minimally disrupt the way rotator cuff repairs are performed, simplifying the delivery of the product into the interface between the bone and the tendon flipping the script compared to most of the products today for augmentation.” Nikhil Verma, MD. Professor and Director, Division of Sports Medicine, Fellowship Director, Department of Orthopedics, Rush University Medical Center, Team Physician Chicago White Sox and Chicago Bulls, Board Director, Tetrous, Inc.
- [About Us](https://tetrous.com/about-us/): Tetrous, Inc. is a privately owned regenerative medicine company guided by a team of key thought-leader surgeons and regenerative medicine scientists and is led by experienced medical device executives with significant prior successes in the musculoskeletal space.
- [Distributors](https://tetrous.com/distributors/): Distributors Animations EnFix RC Animation.mp4EnFix TAC Animation.mp4 Customer Service Docs EXAMPLE - Tetrous Product Request FormTetrous General Charge SheetTetrous New Account Set Up FormTetrous Product Request FormTetrous Return Authorization FormCustomer Feedback FormEnFix Consignment - Distributor Form Distributor Docs Direct Deposit Enrollment Form Surgical Procedure Videos TAC Full Case with Audio.mov VAC Packet M25-001 Rev 00 VAC Packet FINAL.pdfM24-001 Rev06 EnFix White Paper FINAL.pdfP5016 rev01 EnFix Brochure - Shoulder FINAL.pdf W9s W-9 Form_Blank.pdfW-9 Tetrous.pdf
- [News & Events](https://tetrous.com/news-events/): Oct 24, 2024
- [Resources – Old](https://tetrous.com/resources-old/): Download the EnFix brochure and white paper for more information on how EnFix RC™ and EnFix TAC® enhance rotator cuff injury healing at the enthesis and the technologies and techniques involved.
- [Test Page](https://tetrous.com/test-page/): Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam ultrices vitae lectus at tincidunt. Quisque euismod ultrices vestibulum. Nullam eu tortor quis quam cursus consectetur iaculis nec nibh. Suspendisse commodo tincidunt eros, ut accumsan mauris pretium ac. Nunc a nunc pellentesque, fermentum urna ac, accumsan mi. Aliquam non ipsum dolor. Donec sit amet purus non turpis iaculis eleifend. Nam in congue enim. Integer at consectetur urna. Aliquam felis tortor, aliquam ut tortor at, iaculis mollis ex. Aenean a tellus ut velit mattis lobortis. Mauris quis nulla sed lectus ultrices vehicula ut vitae tortor. Nunc neque est, convallis nec ligula non, egestas vestibulum nisl. Praesent at viverra mi. Vestibulum orci felis, congue vitae tincidunt ut, auctor non nisi. Quisque dictum porttitor sem, et mollis neque auctor et.
- [Instructions for Use](https://tetrous.com/instructions-for-use/): This website provides Instructions for Use (IFU) documents for products offered by Tetrous, Inc. These prescription-use products are intended for use by healthcare professionals only. The IFU documents on this site are valid only on the date printed. Responsibility resides with the healthcare professional to print the IFU document on the day the product is intended to be used to ensure the most current IFU is referenced. Clinical indications of products published on the Tetrous, Inc. website are subject to individual national regulatory authorization. To view and print a PDF version of the Instructions for Use, click on the appropriate link below to select the product. If you require additional assistance, or to request a hard copy of the Instructions for Use, please Contact Us. 
- [Certificates](https://tetrous.com/certificates/): Tetrous distribution is through Millstone Medical Outsourcing.  Below are links to Millstone's certifications.
- [Our Story](https://tetrous.com/our-story/): Use this section to describe your company and the services you offer. You could share your company’s story and details about why you are in business. The goal is to create a connection with the visitor and give them confidence to work with you.
- [Our Services](https://tetrous.com/our-services/): A short description of this service and how it helps clients.
- [Contact Us](https://tetrous.com/contact-us/): Phone:  +1 331-307-7499Email:  customerservice@tetrous.com
- [Sample Page](https://tetrous.com/sample-page/): This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: